Recent Searches

    New York to Increase Medical Cannabis Access and Research

    By

    This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live

    New York’s Office for Cannabis Management (OCM) is expanding access to and research on medical cannabis through the expansion of Registered Organization (RO) Applications and the launch of Cannabis Research License Applications.

    In a bid to expand patient access to medical cannabis in New York, the OCM has expanded its RO Applications, which will now be an exclusively online process.

    Applicants looking to be approved must submit a nonrefundable application fee of $10,000 to apply, and, the OCM has stated, must exhibit “cultural, linguistic, and medical competence” in order to cater for patients.

    The OCM stated: “This innovative approach demonstrates OCM’s continued commitment to creating a more inclusive and effective cannabis industry in the State.

    “Additionally, this approach distinctively puts an emphasis on collaboration; encouraging applicants to form partnerships that demonstrate their collective capability to fulfill their obligations and serve their respective communities effectively. This collaborative model addresses the shortcomings of the previous approach to integrating ROs, aligning with the evolving standards of today’s market.”

    Additionally, the New York State Cannabis Control Board (CCB) has voted in favour of launching Cannabis Research Licence Applications that will enable the production, processing, purchase and/or possession of cannabis for research purposes.

    The licenses will enable researchers, scientists, physicians, cultivators and others to study cannabis to potentially lead to new innovations in treatments.

    Applications for a Cannabis Research License will cost $250 for the application fee and $500 for a license fee.

    In a statement, Nakesha Abel, Deputy Director for Health and Research for New York’s Office of Cannabis Management, commented: “As we continue to build a comprehensive regulated cannabis market, New York State is poised to lead the nation in cannabis research and science.

    “For far too long, the ability to conduct high-quality scientific investigations on cannabis has been limited by too many barriers.

    “With the New York State Cannabis Research License, researchers will now be able to perform studies on the cannabis products that patients and consumers are utilising in the real world.”

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.